Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dienogest/Ethinylestradiol vs Yasmin for Cycle Control
NCT01557023Phase 3Withdrawn
- Sponsor
- Eurofarma
- Start
- Jul 2013
- Primary completion
- Dec 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of dienogest + ethinyl estradiol in contraception, sponsored by Eurofarma. Planned start Jul 2013; status: withdrawn.
02
Drugs
dienogest + ethinyl estradiol
03
Conditions
contraception
Beyond the preview
Go deeper on NCT01557023.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01557023.